➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Baxter
Johnson and Johnson
AstraZeneca
Merck

Last Updated: September 19, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR LOSARTAN POTASSIUM

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Losartan Potassium

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00090259 ↗ Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948) Completed Merck Sharp & Dohme Corp. Phase 3 2001-12-01 This is a multicenter study to evaluate potential decrease in hospitalization events and time between events and increasing longevity in patients with symptomatic congestive heart failure and intolerant of first-line medication for heart failure. This study will evaluate if higher doses of the investigational drug given daily will be superior to the lower dose of the same investigational drug given daily.
NCT00140985 ↗ Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213) Completed Merck Sharp & Dohme Corp. Phase 4 2000-02-01 Antiproteinuric Efficacy of Losartan Potassium in Patients with Non-Diabetic Proteinuric Renal Diseases.
NCT00157963 ↗ Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314) Completed Merck Sharp & Dohme Corp. Phase 4 2005-02-01 An efficacy and safety study of hydrochlorothiazide (+) losartan potassium compared to amlodipine at week 12 in Korean patients with essential hypertension
NCT00185094 ↗ A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to Insulin Completed Daiichi Sankyo Inc. Phase 4 2004-02-01 To examine the effect of three different blood pressure medications on the insulin sensitivity in overweight patients with high blood pressure.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Losartan Potassium

Condition Name

Condition Name for Losartan Potassium
Intervention Trials
Hypertension 26
Healthy 7
Kidney Disease 3
Essential Hypertension 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Losartan Potassium
Intervention Trials
Hypertension 18
Kidney Diseases 6
Renal Insufficiency, Chronic 3
Diabetes Mellitus, Type 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Losartan Potassium

Trials by Country

Trials by Country for Losartan Potassium
Location Trials
United States 99
China 22
India 4
Italy 3
Brazil 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Losartan Potassium
Location Trials
California 10
Texas 9
Florida 6
Ohio 6
Indiana 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Losartan Potassium

Clinical Trial Phase

Clinical Trial Phase for Losartan Potassium
Clinical Trial Phase Trials
Phase 4 16
Phase 3 11
Phase 2/Phase 3 1
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Losartan Potassium
Clinical Trial Phase Trials
Completed 43
Recruiting 9
Not yet recruiting 6
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Losartan Potassium

Sponsor Name

Sponsor Name for Losartan Potassium
Sponsor Trials
Merck Sharp & Dohme Corp. 12
Torrent Pharmaceuticals Limited 4
Roxane Laboratories 4
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Losartan Potassium
Sponsor Trials
Other 41
Industry 32
NIH 10
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
McKesson
Express Scripts
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.